Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
about
The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-AnalysisTreatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic ReviewTreatment of American tegumentary leishmaniasis in special populations: a summary of evidence.Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in KabulClinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine AntimoniateDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil.A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guideSpecies typing in dermal leishmaniasisIntralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centreDevelopment of a scoring system using a statistical model to predict cure status in patients with cutaneous leishmaniasis.Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis.Can a simple outpatient-based treatment be used to treat cutaneous leishmaniasis in young children? A Critically Appraised Topic.Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis.Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis.Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).High-resolution infrared thermography: a new tool to assess tungiasis-associated inflammation of the skin.Clinical and laboratory profiles of patients with early spontaneous healing in cutaneous localized leishmaniasis: a historical cohort study.Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.Interventions for Old World cutaneous leishmaniasis.Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia.Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment.Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan.Intralesional Infiltration with Meglumine Antimoniate for the Treatment of Leishmaniasis Recidiva Cutis in Ecuador.Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.An international qualitative study exploring patients' experiences of cutaneous leishmaniasis: study set-up and protocol.Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
P2860
Q26764752-9ABED1E7-C601-4474-B736-91E7A53F07A4Q26764786-20C73CA1-108A-4062-B881-C4425D393930Q27022964-3FB6D650-CDEB-43E3-A131-3922369C834FQ28539775-5DE9DF5E-6EEA-43D8-8DA7-AB6349CFE34AQ28552530-0CA4A5AC-530A-48A8-9ECD-41F3D6121D84Q30275257-D1FB7C9A-1075-4BA0-B992-F0E883457893Q33739398-5DFD2DE2-32D5-4373-8CC2-8A7393F5525AQ34643119-B2E3359A-0CF4-4FD3-A2AD-EA22CB50CBACQ35160905-78DB251A-9884-4B57-AA7A-9100F8C88972Q35482538-8ACE3941-AF95-45BB-A4E6-4E54880EB7EBQ37167729-448D631B-6CBC-4AF2-A93F-380AC5A1CBD9Q37715238-0C6C8C2D-6DC2-4F9D-86B4-D5244C2C5602Q38195310-5B1D7428-636E-4311-AA8D-9E0680FB9B55Q38263615-B5AB1797-D758-4CF4-889B-7B4FEDD1D7C0Q39004272-A775CEBD-047F-44DC-8008-3A1F638C2591Q40124194-D9ED720C-D38B-4035-AEB5-6B00D741D5F6Q40418320-A53C8765-1178-43F7-8792-812A46940236Q40746044-ACC5E935-74FD-4B4A-82D8-74831EAFFC85Q40968887-5415E0DF-2495-4525-9330-D4B54B37140BQ41036737-39940253-E4B5-4C2F-B3BE-D592AE8CDFD9Q41336329-B31A87E4-D2A5-45F0-BF03-39165EF71C5FQ41677439-BA22EAB3-A530-4596-94BC-AABD50BBDEA5Q42708364-40DC3DC6-0006-4552-A59B-C2D06ECF945AQ46250558-AFDB93F7-2A54-44E8-AFD0-856E3C83E847Q46258168-13844183-2C66-426A-A33E-6395253F0829Q47118269-6C1EB5E3-5ADF-4C32-9177-50E81809CFC1Q47735229-DA1E8B4C-5B91-4945-9D54-F7F10E7CC240Q48520561-F828E3A0-7A5B-4381-A02C-8E68B3912739Q49398553-5C02E4A7-DF8B-495D-A588-AD467D6C9F5BQ49542422-74B83602-9DB8-4E35-BE00-DC88B0BC732CQ50088456-22E2D405-6EA5-474C-8B92-C81CAF9B1D50Q52685080-8AD8EC6C-068E-46FA-87FF-7FA2C07EF1EFQ55262326-4BF42BB5-F137-41A7-BA5F-F7DEA7278356Q55398190-DC48D544-D1D7-408D-96EC-C273F236C428
P2860
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@ast
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@en
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@nl
type
label
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@ast
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@en
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@nl
prefLabel
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@ast
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@en
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@nl
P2093
P2860
P50
P1476
Methodology of clinical trials ...... s for cutaneous leishmaniasis.
@en
P2093
Alan Magill
Byron Arana
Farrokh Modabber
Jorge Alvar
Olivier Lapujade
P2860
P356
10.1371/JOURNAL.PNTD.0002130
P407
P5008
P577
2013-03-21T00:00:00Z